Clinical trial · Interventional
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
Effect of Oscillating Positive Expiratory Pressure Therapy on the Frequency of Pulmonary Atelectasis in Thoracic Cancer Patients Undergoing Chest Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized clinical study aims to assess the use of an oscillating positive expiratory pressure device (AEROBIKA) in patients with thoracic neoplasms who undergo chest surgery. The main questions it aims to answer are: If the use of the AEROBIKA device reduces the incidence of atelectasis in oncological patients undergoing lung resection. If the use of the AEROBIKA device reduces hospital readmission and days of hospital stay. Participants who accept to participate will be sorted to receive a conventional rehab therapy (group A), otherwise a conventional rehab therapy plus AEROBIKA device (group B). Researchers will compare patients from group A versus group B to see if patients develop atelectasis.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Mediastinal Tumor | Mediastinal Neoplasm | ALIAS | 0.90 |
| Pleural Tumor | Pleural Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| oscillating positive expiratory pressure device | Device | — | UNRESOLVED |
| Pulmonary rehabilitation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Conventional rehabilitation
- description
- Patients will receive conventional pulmonary rehabilitation
- interventionNames
- Procedure: Pulmonary rehabilitation
- type
- EXPERIMENTAL
- label
- AEROBIKA
- description
- Patients will receive conventional pulmonary rehabilitation in addition to an oscillating positive expiratory pressure device
- interventionNames
- Device: oscillating positive expiratory pressure device
- Procedure: Pulmonary rehabilitation
Primary outcomes (1)
- measure
- Reduction of lung atelectasis
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with a confirmed diagnosis of lung cancer, mediastinal tumors or mesothelioma who are candidates for surgical resection through thoracotomy or sternotomy. 2. Measurable disease 3. Age from 18 to 75 years 4. Peak Expiratory flow of 10 liters/min 5. Eastern Cooperative Oncology Group (ECOG) performance status 0-2 6. Karnofsky score 70-100 7. Patients willing and able to comply with all study procedures and follow-up visits. 8. Patients who agree to participate and sign an informed consent form Exclusion Criteria: 1. Unstable systemic disease, including active infection, cardiac or hemodynamic diseases or neurological diseases. 2. Patients with cognitive impairment who are not able to perform the pulmonary rehabilitation exercises. 3. Oral cavity or facial trauma. 4. Esophagus surgery 5. Active hemoptysis 6. Tympanic rupture or middle ear pathology.
References
Publications (0)
Data not yet available